Clinical Trial Update: PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

View source ↗

Summary

A completed prospective clinical trial evaluating the MammaPrint genomic assay in patients with an intermediate recurrence score to guide treatment decisions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Agendia | Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast | Status: COMPLETED